(Q53239126)
Statements
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. (English)
M Farlow
R Anand
J Messina
R Hartman
J Veach
1 January 2000
44
4
236-241
scientific article published in January 2000